Understanding early pregnancy loss through genetic analysis
Official title: Study of Product of Conception Derived From Ultrasound-guided Manual Vacuum Aspiration
Run by Chinese University of Hong Kong · NCT05825183 · Data updated 2026-11-12
This study is trying to find out if genetic and immune factors play a role in early pregnancy loss by analyzing tissue from miscarriages to see if there are any hidden genetic issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | May 30, 2023 |
| Main results expected | May 31, 2028 |
| Study ends | October 31, 2028 |
| Registry record updated | March 20, 2025 |
| Trial ID | NCT05825183 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older who have experienced a first trimester miscarriage or termination of pregnancy and are suitable for manual vacuum aspiration.
✕Probably not a fit
Patients who are not feasible candidates for the MVA procedure due to conditions like cervical stenosis or uterine malformations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the genetic and immunological factors contributing to early pregnancy loss, which affects approximately one in four women. It focuses on analyzing products of conception obtained through ultrasound-guided manual vacuum aspiration (MVA) to identify chromosomal abnormalities and other genetic factors that may not be detectable by conventional karyotyping. The study utilizes next-generation sequencing (NGS) to enhance the detection of genomic variants, including copy-number variants and low-level chromosomal mosaicisms. By improving the understanding of the genetic underpinnings of miscarriage, the study seeks to provide insights into potential causes and future interventions.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for early pregnancy loss, helping to identify underlying genetic causes and guiding future reproductive decisions.
How similar studies have gone: While the approach of using next-generation sequencing for genetic analysis in early pregnancy loss is gaining traction, this specific methodology and its application in this context may be novel and less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women 18 years old or above 2. Women with miscarriage or TOP who are suitable candidates for MVA * first trimester miscarriage or TOP * No fetal heart beat or TOP in those with CRL 25mm * incomplete miscarriage or TOP with POG \<5cm * hemodynamically stable, * tolerates well with speculum examination Exclusion Criteria: 1. Women who are not feasible for the MVA procedure * cervical stenosis * fibroid uterus \>12 weeks in size * known uterine malformation * bleeding disorder * clinically sepsis * inability to tolerate pelvic examination 2. History of psychological/ psychiatric problem 3. Patient refusal
Where it's running
-
Prince of Wales Hospital
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Pui Wah Jacqueline Chung — Prince of Wales Hospital, Shatin, Hong Kong
- Study coordinator: Pui Wah Jacqueline Chung
- Email: jacquelinechung@cuhk.edu.hk
- Phone: 35051537
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating long-term visual outcomes of pediatric cataract surgery
This study is testing how well cataract surgery works for children over time and looking at factors that might affect their vision.
-
Evaluating long-term visual outcomes after cataract surgery in high myopia patients
This study looks at how cataract surgery affects vision over time in people with severe nearsightedness compared to those with regular age-related cataracts.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Ultrasound-guided microwave ablation for benign thyroid nodules
This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.
-
Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia
This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.
-
Metomidate PET-CT vs Usual Care for Primary Aldosteronism
This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.